Washington, DC 20006-5349
HELPLINE
BY JESSICA BLACKFORD-CLEETON A large number of warriors diagnosed with mesothelioma are over the age of 65, but there are several cases of diagnosis in…
On Friday, October 7, the Meso Foundation and the mesothelioma community will gather for the last time in 2016 for a one-day conference in Chicago,…
Dr. Raffit Hassan of the National Cancer Institute, and former chair of the Mesothelioma Applied Research Foundation’s Science Advisory Board, announced results of the Phase…
“I can’t believe we’re at a point at which we’re discussing fertility at a meeting about mesothelioma,” said a moderator during a session at the…
As of June 1, Dr. Kiran Turaga, a surgeon from the Medical College of Wisconsin, will be joining Dr. Hedy Kindler and the University of…
For cancer patients, a diagnosis is generally followed by staging. Among other things, the stage of a cancer tells the patient and physician if the…
On April 12, Friends of Cancer Research held a briefing on Capitol Hill on the topic of Breakthrough Therapy Designation: Successes, Lessons Learned and Future…
The Meso Foundation recently hosted a Meet the Mesothelioma Experts session with Dr. Raphael Bueno, the chief of thoracic surgery at Brigham and Women’s Hospital…
Prevention of mesothelioma can take several different shapes. Avoiding exposures to asbestos is one such method. However, while theoretically valid, in reality this method falls…
The Meso Foundation released a statement from its executive director, Mary Hesdorffer, APRN, about AstraZeneca’s tremelimumab trial for mesothelioma. In an AstraZeneca press release issued…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
